February 2013 Issue of MMM
FEBRUARY 2013 issue
Pharma's "digital adoption" conversation has almost always focused on new technologies, new channels, new audiences and new skills. But that's changing fast.
The MM&M Awards 2013 program is now open for business. This is your chance to put your best work forward, showcase your talents and get ...
Savvy, influential patients have pharma's attention and are growing relationships with industry. How firms have just begun to tap the potential of this emerging segment
Managed care and PBMs are calling the shots on coverage. Before you decide on marketing and pricing, know what matters to them. Seven moves to ...
The Medical Advertising Hall of Fame's three new members have each made lasting contributions. Digital media, healthcare advertising and promotional analysis still bear their imprint
With more sources of medical info than ever—both in print and online—many doctors are making the decision to unplug from pharma. How to reach them ...
Ryan Cohlhepp—Senior Director, Head of US Marketing, Millennium: The Takeda Oncology Company
Companies are looking carefully at the rare disease area now. But there's a steep curve, as firms in this burgeoning space face a host of ...
A foundational premise of agency-of-record and preferred-provider relationships has a fatal flaw
The major flu vaccine still in use, with technology essentially unchanged since the 1950s, is the vaccine manufactured using cultures of billions of hens' eggs. ...
What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur.
The doctors who said in 2012 that drug company-sponsored lunches couldn't sway their prescribing are being undercut by a study published in JAMA's Internal Medicine.
The warfarin-replacement market has been bracing for the entry of Eliquis since well before the drug won FDA approval in December
News on IMS Health, Televox, the American Academy of Nurse Practitioners and the American College of Nurse Practitioners
Med Ed Report
MDLinx owner M3 Group is partnering with Argentine online physician network Medcenter on a content-sharing deal that will expand the former's in-language reach
Big Data is powering Joslin Diabetes Center's performance-improvement CME, thanks in part to education grants from four pharma companies.
Advocacy groups and physicians call on the Office of Management and Budget to release final regulations for the Physician Payments Sunshine Act.
News on Wentz-Miller Global Services, Plannernet, QuantiaMD and Meeting Professional International
A new Elsevier marketing campaign consists of two mobile units that bring an immersive experience to institutions and individuals
Cloud-based electronic health-record and practice-management provider Athenahealth is buying mobile health firm Epocrates for $293 million in cash
News on Time Inc., WIley and Wolters Kluwer Health
Big Data holds promise for helping pharma boost efficiencies, but the business case for new analytic techniques, in many cases, is still being written. How ...
The Shire ADHD Transitions Challenge will shower $150,000 in awards on eight teams of developers.
A recent survey of the licensing boards which cover the licensure of about 88% of US physicians indicates that what doctors do online after landing ...
News on Psychiatric Times, Manhattan Research and Pew Research Center
Research by Merck bolsters the case for "dual modality" audio/video risk statements
Purdue Pharmaceuticals has taken a big step forward with its new multichannel campaign for its sleep aid, Intermezzo.
FDA has outlined plans to study the use of corrective DTC TV ads as a way of remedying deceptive advertising.
Pfizer and clinical data outfit Humedica jointly announced their intent to collaborate on studies examining the effectiveness of treatments.
Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.
Publicis Healthcare Communications Group is retooling its media offering, placing media talent at each of its shops and creating a centralized media hub for execution.
Draftfcb Healthcare named Joan Bercovitz EVP, managing director of Area 23.
News on Edelman, Ogilvy CommonHealth and 6 Degrees
FDA has never won a First Amendment case, and its string of losses led it to bring this one under false colors
FDA commissioner Margaret Hamburg says that if academia, industry, government scientists and regulators could come together more in pre-competitive collaboration it could get more done
FDA deputy chief counsel for litigation Eric Blumberg told a December conference that "Money is clearly not doing the job...We need to employ a 'bigger ...
The pharmacist in me shudders at the price my family pays for water. But brands matter. So I buy Aquafina
Superstitious or based in fact, fans drive followers to listen and have the power to convert non-believers
Audrey Fleisher, VP, Group Creative Director at Digitas Health
Hans Christian Rohde—Chief Commercial Officer, uniQure
At Work With
Shannon Boyle—SVP, Human Resources, Publicis Healthcare Communications Group
Industry, agency and media hires and promotions
The phrase "perfect storm" powerfully describes the colliding forces in healthcare
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.